Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine

<div>Cutaneous tumor lesions. (a) A painful cutaneous tumor, the top of which showed yellow-colored necrosis, which developed at the left groin 8 months after the second discontinuation of azacitidine. (b) Another cutaneous tumor, which appeared on the left cheek one month after the development of the first cutaneous lesion at the left groin.</div>

Case Reports in Hematology

fig2

Figure 2

Figure 2: Successful Treatment of Myeloid Sarcoma in an Elderly Patient with Myelodysplastic Syndrome with Reduced-Dose Azacitidine 